Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Development & Bioavailability
  6.  » Optimize Your Oral Drug Development Pathway
Webinar icon

Optimize Your Oral Drug Development Pathway

Summary: Of all new chemical entities (NCE) in development, 70% are poorly soluble, and 20% have both solubility AND permeability challenges. As a results, more than 40% NCEs development consistently fail. Selecting the best formulation and drug delivery strategies, to overcome bioavailability challenges at early phase of drug development, is critical to a successful and fast development pathway.

Click here to download